Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03639948 |
Title | Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer (NeoPACT) |
Acronym | NeoPACT |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University of Kansas Medical Center |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
The University of Kansas Cancer Center (KUCC) | Fairway | Kansas | 66205 | United States | Details | |
The University of Kansas Cancer Center, West Clinic | Kansas City | Kansas | 66112 | United States | Details | |
The University of Kansas Cancer Center, Westwood Campus | Kansas City | Kansas | 66205 | United States | Details | |
University of Kansas Cancer Center | Kansas City | Kansas | 66205 | United States | Details | |
The University of Kansas Cancer Center, Overland Park Clinic | Overland Park | Kansas | 66210 | United States | Details | |
The University of Kansas Cancer Center, North Clinic | Kansas City | Missouri | 64154 | United States | Details | |
The University of Kansas Cancer Center, Lee's Summit Clinic | Lee's Summit | Missouri | 64064 | United States | Details | |
The University of Kansas Medical Center | North Kansas City | Missouri | 64116 | United States | Details | |
Texas Oncology- Baylor | Dallas | Texas | 75246 | United States | Details |